Kotaku
Quartz
The Root
The Inventory
Search
Free Newsletters
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
Editions
Español
Deutsch
Français
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
About
Editions
Español
Deutsch
Français
Explore our other sites
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
WMT
+1.03%
$88.69
+$0.90
TGT
-0.26%
$104.09
-$0.28
AMZN
+0.83%
$191.84
+$1.58
TSLA
+3.99%
$269.49
+$10.33
NVDA
+0.83%
$109.28
+$0.90
MSFT
+1.61%
$381.45
+$6.06
MCD
+0.27%
$313.22
+$0.85
GS
+0.14%
$547.05
+$0.76
COST
+0.52%
$950.71
+$4.93
META
+1.48%
$584.92
+$8.56
WMT
+1.03%
$88.69
+$0.90
TGT
-0.26%
$104.09
-$0.28
AMZN
+0.83%
$191.84
+$1.58
TSLA
+3.99%
$269.49
+$10.33
NVDA
+0.83%
$109.28
+$0.90
MSFT
+1.61%
$381.45
+$6.06
MCD
+0.27%
$313.22
+$0.85
GS
+0.14%
$547.05
+$0.76
COST
+0.52%
$950.71
+$4.93
META
+1.48%
$584.92
+$8.56
Markets
RECENT NEWS
An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup
March 14, 2025
Viking Therapeutics closer to bringing its Ozempic competitor to market
March 11, 2025
Novo Nordisk's Ozempic successor disappointed Wall Street again
March 10, 2025
The race for the next Ozempic is on
January 21, 2025
Advertisement